A trial emulation study of veterans with COVID-19 has found that the use of the antiviral nirmatrelvir–ritonavir was not effective for reducing the risk for many post-COVID-19 conditions, including cardiac, pulmonary, renal, ...
Oct 30, 2023
0
2
A prediction model can be used to identify people affected by venous thromboembolism who have only a low risk of recurrence and may not require long-term blood thinning. The validity of this Vienna Prediction Model developed ...
Oct 4, 2023
0
0
Women who use non-steroidal anti-inflammatory painkillers alongside hormonal contraception appear to be at a small increased risk of blood clots known as venous thromboembolism (VTE), finds a large Danish study published ...
Sep 6, 2023
0
22
For patients with venous thromboembolism (VTE) continuing warfarin or direct oral anticoagulants (DOACs) beyond six months, the risk for recurrent VTE is lower with DOACs, according to a study published online Aug. 15 in ...
Aug 21, 2023
0
0
People who are regular cannabis users are at an increased risk of experiencing complications before, during, and after surgery, according to a study by researchers with UTHealth Houston published today in JAMA Surgery.
Jul 5, 2023
0
2
The American College of Chest Physicians (CHEST) recently released a new clinical guideline on antithrombotic therapy in arterial thrombosis andthromboembolism in COVID-19. Published in the journal CHEST, the guideline contains ...
Jun 29, 2023
0
1
Direct oral anticoagulant (DOAC) treatment is noninferior to low-molecular-weight heparin (LMWH) for preventing recurrent venous thromboembolism (VTE) in cancer patients, according to a study published online June 2 in the ...
Jun 6, 2023
0
2
Research led by the Cleveland Clinic in Ohio evaluated postoperative recovery rates from elective surgery in a study, "Association Between Mobilization and Composite Postoperative Complications Following Major Elective Surgery," ...
Atopic dermatitis (AD) in adulthood is associated with an increased risk for venous thromboembolism (VTE), according to a study published online May 31 in JAMA Dermatology.
Jun 1, 2023
0
0
HealthPartners Institute researchers have published new data in JAMA Network Open that show monovalent COVID-19 booster vaccinations administered in early pregnancy (before 20 weeks' gestation) were not associated with miscarriage. ...
May 19, 2023
0
60
